NCT04086251 is a NA clinical trial of Gaido in Cancer, sponsored by Gaido Health.

Who is sponsoring NCT04086251?

NCT04086251 is sponsored by Gaido Health.

What drugs are being tested in NCT04086251?

Interventions in NCT04086251: Gaido.

Is NCT04086251 still recruiting?

NCT04086251 is currently status unknown. Last updated 11 September 2019.

Last reviewed 2019-09-11 · How we verify

NCT04086251

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Remote Electronic Patient Monitoring in Oncology Patients

Status unknown NA Last updated 11 September 2019

What this trial tests

NA trial testing Gaido in Cancer in 30 participants. Status unknown.

Timeline

9 September 2019

Primary endpoint
30 November 2019

31 December 2019

Quick facts

Lead sponsor	Gaido Health
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	prevention
Enrollment	30
Start date	9 September 2019
Primary completion	30 November 2019
Estimated completion	31 December 2019
Sites	1 location across United States

Drugs / interventions tested

Gaido

Conditions studied

Cancer — all drugs for Cancer →

Sponsor

Gaido Health

Who can join

18 and older, any sex, with Cancer. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The goal of this research is to study an intervention, which the investigators call "Remote Electronic Patient Monitoring," that entails vital sign data (enabled with smart algorithms for notification) and patient-reported outcomes (PROs), (such as physical and psychological symptoms) intended to address and manage any concerning issues and or diagnoses identified. Specifically, the plan is a study of oncology patients who will use the Gaido system for up to 21 days or per physician order.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Cancer

Currently open trials in the same condition.

NCT07390045 — Exercise and Cognitive Rehabilitation Interventions for Older Cancer Survivors · NA · recruiting
NCT07528547 — Hypersight and Ethos In Pediatric Radiotherapy · NA · recruiting
NCT07481890 — Feasibility and Efficacy of the EMDR Toolbox Method in Cancer Patients. · NA · recruiting
NCT07402057 — Implementation and Evaluation of a Program Aimed at Facilitating Palliative Care Conversations · NA · recruiting
NCT07305740 — On-Trac: An Online Intervention for Cancer Survivors Managing Anxiety · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04086251 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Gaido Health
Last refreshed: 11 September 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04086251.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing